Concepedia

Hardikkumar Jetani

HJ

Statistics

Publications

5

Citations

336

H-Index

5

Active since

2013

Affiliations

Universitätsklinikum Würzburg(Current)

National Institute of Pharmaceutical Education and Research

University of Würzburg

University Hospital Regensburg

DRK-Blutspendedienst Baden-Württemberg - Hessen

Hardikkumar Jetani is an author at Universitätsklinikum Würzburg specializing in molecular biology, immunology, and natural sciences.

ORCID

Top concepts

Publications per year

2013–2021

5

Publications

5

CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib

Hardikkumar Jetani, Irene García‐Cadenas, Thomas Nerreter et al. · Leukemia · 2018 · 183 citations

, , +4

Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia

Hardikkumar Jetani, Almudena Navarro‐Bailón, Marius Maucher et al. · Blood · 2021 · 97 citations · Full text

Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia

Andoni Garitano-Trojaola, Ana Sancho, Ralph Götz et al. · Communications Biology · 2021 · 28 citations · Full text

, , +14

Nucleic Acid Aptamers as Stabilizers of Proteins: The Stability of Tetanus Toxoid

Nishant Kumar Jain, Hardikkumar Jetani, Ipsita Roy · Pharmaceutical Research · 2013 · 17 citations

, , +7

Nucleic Acid Aptamers Stabilize Proteins Against Different Types of Stress Conditions

Hardikkumar Jetani, Ankan K. Bhadra, Nishant Kumar Jain et al. · Journal of Pharmaceutical Sciences · 2013 · 11 citations

, , +7

1–5 of 5